The research center of the Quebec Mental Health Institute (Institut universitaire en santé mentale de Québec - IUSMQ), in partnership with other Canadian institutions, will receive 3,3M$ from the Canadian Brain Research Fund to develop and manage the Canadian Neurophotonics Platform, over the next 3 years. The platform will be managed by the Research Centre of the IUSMQ, who will lead the initiative. The project aims to develop, test and promote new neurophotonics tools putting the power of optics and photonics to the service of neuroscience and brain research.
In a special section of the newspaper Le Devoir published for the 50 years of the "Fonds de Recherche du Québec - Santé", FRQS, Yves De Koninck explains the importance of this funding agency for Quebec researchers, and the advantage it gives then at the national and international level. Read the full article in the September 13 edition of Le Devoir (in French only): Le FRQS, un soutien essentiel pour les chercheurs
Listen to a recent interview with Jean-Martin Beaulieu, who recently won the 2014 IMHRO / Johnson & Johnson Rising Star Translational Research Award. He explains his research and his aim to develop safer, targeted mood stabilizing drugs by testing, in cell culture and in mice, small molecules which his past research suggests might replicate the therapeutic effect of lithium with minimal side effect.
The interview is available here:
The recent discoveries by Robert Bonin and Yves De Koninck are featured on PBS's Nova Next website. The article features interviews with pain specialists Allan Basbaum, from the University of California, San Francisco and Ted Price, from University of Texas-Dallas, in addition to Université Laval's De Koninck.
Congratulations to Jean Martin Beaulieu who was recently awarded an IMHRO/Johnson & Johnson Rising Star Award, accompanied by a $250 000 grant over 3 years.
Photo: Marc Robitaille